Finance

Lists
524824:BOM
Bal Pharma Ltd
₹97,10
-1,27%
(-1,25) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524824...
Open
₹97,90
High
₹100,45
Low
₹96,60
Mkt. cap
1,54 mjd
Avg. vol.
9,28 k
Volume
192,00
Dividend
1,24%
Quarterly dividend
₹0,30
Ex-dividend date
17 Sep. 2026
P/E ratio
21,40
52-wk high
₹124,68
52-wk low
₹59,69
EPS
₹4,54
Shares outstanding
14,17 m
No. of employees
939
Open
₹97,90
High
₹100,45
Low
₹96,60
Mkt. cap
1,54 mjd
Avg. vol.
9,28 k
Volume
192,00
Dividend
1,24%
Quarterly dividend
₹0,30
Ex-dividend date
17 Sep. 2026
P/E ratio
21,40
52-wk high
₹124,68
52-wk low
₹59,69
EPS
₹4,54
Shares outstanding
14,17 m
No. of employees
939
News stories
From web sources and news partners
About Bal Pharma Ltd
CEO-
Employees939
Founded1987
Headquarters-
SectorPharmaceutical industry
Websitebalpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
740,25 m
876,90 m
840,76 m
886,16 m
Cost of goods sold
399,35 m
461,60 m
436,91 m
511,52 m
Cost of revenue
399,35 m
461,60 m
436,91 m
511,52 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
162,71 m
173,24 m
189,03 m
170,64 m
Operating expense
306,30 m
352,15 m
346,41 m
322,99 m
Total operating expenses
705,66 m
813,74 m
783,32 m
834,51 m
Operating income
34,59 m
63,15 m
57,43 m
51,66 m
Other non operating income
11,16 m
3,26 m
-37,86 m
4,38 m
EBT including unusual items
7,17 m
17,91 m
32,18 m
11,38 m
EBT excluding unusual items
7,17 m
17,91 m
31,04 m
11,38 m
Income tax expense
-
-
-3,86 m
-
Effective tax rate
-
-
-12,00%
-
Other operating expenses
120,88 m
146,61 m
126,80 m
124,52 m
Net income
7,10 m
17,80 m
35,94 m
11,24 m
Net profit margin
0,96%
2,03%
4,27%
1,27%
Earnings per share
-
-
-
-
Interest and investment income
-
-
9,53 m
-
Interest expense
-38,58 m
-48,51 m
-21,20 m
-44,66 m
Net interest expenses
-38,58 m
-48,51 m
-11,67 m
-44,66 m
Depreciation and amortization charges
22,71 m
32,30 m
30,58 m
27,82 m
EBITDA
58,55 m
77,54 m
72,77 m
79,35 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme